Last update 01 Nov 2024
Inmunotek SL

Inmunotek SL

Private Company|
1992|
Spain
|
50-100
|

Overview

Basic Info

Introduction
Inmunotek is a pharmaceutical laboratory situated in Alcalá de Henares - Madrid, which specializes in researching, developing, manufacturing, and marketing products for the diagnosis and treatment of diseases related to allergy and immunology in both human and veterinary pathology. The company employs a multidisciplinary team of professionals comprising pharmacists, doctors, biologists, chemists, and engineers, with specialists in immunology, allergy, and microbiology. Additionally, they have technical specialists in various production and control areas, as well as personnel dedicated to R&D and technological innovation. Inmunotek adheres to GMP standards and operates well-equipped laboratories for production and quality control. The company also has facilities for the production of biological raw materials such as bacteria, fungi, and mites, as well as specific facilities for the sanitary products they manufacture.

Tags

Respiratory Diseases
Immune System Diseases
Infectious Diseases
Biological products
Live attenuated vaccine
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
Biological products2
Live attenuated vaccine1
Prophylactic vaccine1
Chemical drugs1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
2
Phase 2 Clinical
Phase 3 Clinical
2
4
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MG-01
Allergic asthma
More
Phase 3
T-517
Allergic asthma
More
Phase 3
MV-130
-
Phase 2 Clinical
Birch cluster immunotherapy(Inmunotek SL)
Conjunctivitis, Allergic
More
Phase 2
MM-09(Inmunotek SL)
Rhinitis, Allergic
More
IND Approval
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free